Trends in Lyme disease incidence in England, 2013 to 2024

Official Lyme disease incidence figures for England are based on the number of cases with a laboratory-confirmed diagnosis from the national reference laboratory. However, these figures underestimate the true incidence of acute cases since patients can also be diagnosed clinically without the need for laboratory testing. The use of a multiplication factor has been proposed to estimate total Lyme disease incidence from the number of laboratory-confirmed cases. The current multiplication factor is derived from data spanning 1998-2016 and is thought to be outdated, in part due to the introduction of new national Lyme disease management guidance in 2018. The aim of this study was to analyse more recent laboratory and primary care data to identify trends in case numbers and to derive updated estimates of the total annual number of acute Lyme disease cases in England. Data spanning 2013-2024 from the national reference laboratory and a primary care data source were analysed using seasonal time series models. The presence of structural breaks was investigated using the PELT or BinSeg methods, and annual multiplication factors were estimated using a Poisson regression model. No substantial change was found in the number of laboratory-confirmed Lyme cases from 2013 to 2024 in England, whereas the number of cases diagnosed in primary care increased significantly over the same period, with an average of an additional 498 cases per year. This has increased our best estimate of the multiplication factor from 2.35 (95% confidence interval, 1.81-2.88) to 6.20 (6.17-6.24), which is the average for the years 2020-2024. Use of this updated multiplication factor should improve the accuracy of annual symptomatic Lyme disease case estimates for England.

Authors

Institutions

Publication Details

Journal
PLoS ONE
Published
2026-11-16
DOI
https://doi.org/10.1371/journal.pone.0362881
Primary Topic
Vector-borne infectious diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Trends in Lyme disease incidence in England, 2013 to 2024

Amanda E. Semper, Eva Emanuel, Miranda Ferguson, Roberto Vivancos et al.
PLoS ONE
Vector-borne infectious diseases
article

Trends in Lyme disease incidence in England, 2013 to 2024

Amanda E. Semper, Eva Emanuel, Miranda Ferguson, Roberto Vivancos, Christina Petridou, Mark Gideon Burdon, Jessica I'Anson, Verena FermorDunman, Janie C Olver, Ali Datoo
article en

Abstract

Official Lyme disease incidence figures for England are based on the number of cases with a laboratory-confirmed diagnosis from the national reference laboratory. However, these figures underestimate the true incidence of acute cases since patients can also be diagnosed clinically without the need for laboratory testing. The use of a multiplication factor has been proposed to estimate total Lyme disease incidence from the number of laboratory-confirmed cases. The current multiplication factor is derived from data spanning 1998-2016 and is thought to be outdated, in part due to the introduction of new national Lyme disease management guidance in 2018. The aim of this study was to analyse more recent laboratory and primary care data to identify trends in case numbers and to derive updated estimates of the total annual number of acute Lyme disease cases in England. Data spanning 2013-2024 from the national reference laboratory and a primary care data source were analysed using seasonal time series models. The presence of structural breaks was investigated using the PELT or BinSeg methods, and annual multiplication factors were estimated using a Poisson regression model. No substantial change was found in the number of laboratory-confirmed Lyme cases from 2013 to 2024 in England, whereas the number of cases diagnosed in primary care increased significantly over the same period, with an average of an additional 498 cases per year. This has increased our best estimate of the multiplication factor from 2.35 (95% confidence interval, 1.81-2.88) to 6.20 (6.17-6.24), which is the average for the years 2020-2024. Use of this updated multiplication factor should improve the accuracy of annual symptomatic Lyme disease case estimates for England.

PLoS ONEVol. 21(11)
University of Liverpool (GB), National Institute for Health and Care Research (GB), University of Warwick (GB), Health Protection Research Unit in Emerging and Zoonotic Infections at University of Liverpool (GB), UK Health Security Agency (GB)
Good health and well-being
Vector-borne infectious diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon